Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J9041
    Short Description Injection, bortezomib, 0.1mg
    Long Description Injection, bortezomib, 0.1 mg
    Pricing indicator 51
    Coverage code C
    ASC payment group code YY
    BETOS2 code O1D
    Action code N
    Type of service 1
    Effective date 2023-01-01
    Date Added 2005-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00143909801 J9041 Injection, bortezomib, 0.1mg Bortezomib Hikma Pharmaceuticals USA Inc. 0.1 mg 1 1 35 35
    00409170001 J9041 Injection, bortezomib, 0.1mg Bortezomib Hospira, Inc. 0.1 mg 1 1 35 35
    10019099101 J9041 Injection, bortezomib, 0.1mg Bortezomib BAXTER HEALTHCARE CORP. 0.1 MG 1 1 35 35
    25021024410 J9041 Injection, bortezomib, 0.1mg Bortezomib SAGENT PHARMACEUTICALS, INC. 0.1 MG 1 1 35 35
    43598042660 J9041 Injection, bortezomib, 0.1mg Bortezomib Dr.Reddy's Laboratories, Inc. 0.1 mg 1 1 35 35
    50742048401 J9041 Injection, bortezomib, 0.1mg Bortezomib INGENUS PHARMACEUTICALS, LLC 0.1 MG 1 1 35 35
    55150033701 J9041 Injection, bortezomib, 0.1mg Bortezomib AUROMEDICS PHARMA, LLC 0.1 MG 1 1 35 35
    60505605004 J9041 Injection, bortezomib, 0.1mg Bortezomib APOTEX CORP. 0.1 MG 1 1 35 35
    63020004901 J9041 Injection, bortezomib, 0.1mg Velcade MILLENNIUM PHARMACEUTICALS, INC. 0.1 MG 1 1 35 35
    63323082110 J9041 Injection, bortezomib, 0.1mg Bortezomib FRESENIUS KABI USA, LLC 0.1 MG 1 1 35 35
    68001053436 J9041 Injection, bortezomib, 0.1mg Bortezomib Bluepoint Laboratories 0.1 MG 1 1 35 35
    68001054036 J9041 Injection, bortezomib, 0.1mg Bortezomib BLUEPOINT LABORATORIES 0.1 mg 1 1 35 35
    68001054136 J9041 Injection, bortezomib, 0.1mg Bortezomib BLUEPOINT LABORATORIES 0.1 mg 1 1 35 35
    70710141101 J9041 Injection, bortezomib, 0.1mg Bortezomib ZYDUS PHARMACEUTICALS (USA) INC. 0.1 MG 1 1 35 35
    70860022510 J9041 Injection, bortezomib, 0.1mg Bortezomib ATHENEX PHARMACEUTICAL 0.1 MG 1 1 35 35
    71288011810 J9041 Injection, bortezomib, 0.1mg Bortezomib MEITHEAL PHARMACEUTICALS 0.1 mg 1 1 35 35
    72205018301 J9041 Injection, bortezomib, 0.1mg Bortezomib NOVADOZ PHARMACEUTICALS 0.1 mg 1 1 35 35
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].

    Drug Details

    • Bortezomib is used to treat people with multiple myeloma (a type of cancer of the bone marrow). Bortezomib is also used to treat people with mantle cell lymphoma (a fast-growing cancer that begins in the cells of the immune system). Bortezomib is in a class of medications called antineoplastic agents. It works by killing cancer cells.